World’s Largest Drugmaker Adopts Big Tech Strategy for Preventive Medicine
Eli Lilly (NYSE: LLY) is fundamentally restructuring its business model, moving from reactive pharmacology to a proactive, preventive health ecosystem. By integrating digital health infrastructure and data-driven patient management, the ... Read More